Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Scanlon, KJ' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 38 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Iida, T; Kijima, H; Urata, Y; Goto, S; Ihara, Y; Oka, M; Kohno, S; Scanlon, KJ; Kondo, T
      Hammerhead ribozyme against gamma-glutamylcysteine synthetase sensitizes human colonic cancer cells to cisplatin by down-regulating both the glutathione synthesis and the expression of multidrug resistance proteins

      CANCER GENE THERAPY
    2. Hatanaka, H; Abe, Y; Naruke, M; Asai, S; Miyachi, H; Kawakami, T; Nagata, J; Kamochi, JI; Kijima, H; Yamazaki, H; Scanlon, KJ; Ueyama, Y; Nakamura, M
      Modulation of multidrug resistance in a cancer cell line by anti-multidrugresistance-associated protein (MRP) ribozyme

      ANTICANCER RESEARCH
    3. Nagata, J; Kijima, H; Hatanaka, H; Asai, S; Miyachi, H; Takagi, A; Miwa, T; Mine, T; Yamazaki, H; Nakamura, M; Kondo, T; Scanlon, KJ; Ueyama, Y
      Reversal of cisplatin and multidrug resistance by ribozyme-mediated glutathione suppression

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    4. Irie, A; Kashani-Sabet, M; Scanlon, KJ; Uchida, T; Baba, S
      Hammerhead ribozymes as therapeutic agents for bladder cancer

      MOLECULAR UROLOGY
    5. Suzuki, T; Anderegg, B; Ohkawa, T; Irie, A; Engebraaten, O; Halks-Miller, M; Holm, PS; Curiel, DT; Kashani-Sabet, M; Scanlon, KJ
      Adenovirus-mediated ribozyme targeting of HER-2/neu inhibits in vivo growth of breast cancer cells

      GENE THERAPY
    6. Zhang, YA; Nemunaitis, J; Scanlon, KJ; Tong, AW
      Anti-tumorigenic effect of a K-ras ribozyme against human lung cancer cellline heterotransplants in nude mice

      GENE THERAPY
    7. Tsuchida, T; Kijima, H; Hori, S; Oshika, Y; Tokunaga, T; Kawai, K; Yamazaki, H; Ueyama, Y; Scanlon, KJ; Tamaoki, N; Nakamura, M
      Adenovirus-mediated anti-K-ras ribozyme induces apoptosis and growth suppression of human pancreatic carcinoma

      CANCER GENE THERAPY
    8. Funato, T; Ishii, T; Kambe, M; Scanlon, KJ; Sasaki, T
      Anti-K-ras ribozyme induces growth inhibition and increased chemosensitivity in human colon cancer cells

      CANCER GENE THERAPY
    9. Suzuki, T; Bessho, M; Scanlon, KJ
      Anti-c-erbB2 ribozyme for gene therapy of breast cancer

      GENE THERAPY OF CANCER: METHODS AND PROTOCOLS
    10. Irie, A; Anderegg, B; Kashani-Sabet, M; Ohkawa, T; Suzuki, T; Halks-Miller, M; Curiel, DT; Scanlon, KJ
      Therapeutic efficacy of an adenovirus-mediated anti-H-ras ribozyme in experimental bladder cancer

      ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT
    11. NicAmhlaoibh, R; Heenan, M; Cleary, I; Touhey, S; O'Loughlin, C; Daly, C; Nunez, G; Scanlon, KJ; Clynes, M
      Altered expression of mRNAs for apoptosis-modulating proteins in a low level multidrug resistant variant of a human lung carcinoma cell line that also expresses mdr1 mRNA

      INTERNATIONAL JOURNAL OF CANCER
    12. IRIE A; ENGEBRAATEN O; ANDEREGG B; FLORL A; HALKSMILLER M; SCANLON KJ; KASHANISABET M
      ADENOVIRAL MEDIATED ANTI-H-RAS RIBOZYME FOR THE TREATMENT OF BLADDER-CANCER

      The Journal of urology
    13. KIJIMA H; TSUCHIDA T; KONDO H; IIDA T; OSHIKA Y; NAKAMURA M; SCANLON KJ; KONDO T; TAMAOKI N
      HAMMERHEAD RIBOZYMES AGAINST GAMMA-GLUTAMYLCYSTEINE SYNTHETASE MESSENGER-RNA DOWN-REGULATE INTRACELLULAR GLUTATHIONE CONCENTRATION OF MOUSEISLET CELLS

      Biochemical and biophysical research communications (Print)
    14. Tsuchida, T; Kijima, H; Oshika, Y; Tokunaga, T; Abe, Y; Yamazaki, H; Tamaoki, N; Ueyama, Y; Scanlon, KJ; Nakamura, M
      Hammerhead ribozyme specifically inhibits mutant K-ras mRNA of human pancreatic cancer cells

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    15. SCANLON KJ; KASHANISABET M
      RIBOZYMES AS THERAPEUTIC AGENTS - ARE WE GETTING CLOSER

      Journal of the National Cancer Institute
    16. OHKAWA T; SCANLON KJ
      DELIVERY SYSTEMS OF AN ANTI-H-RAS HAMMERHEAD RIBOZYME AGAINST HUMAN-MALIGNANT MELANOMA

      Cancer gene therapy
    17. CURCIO LD; BOUFFARD DY; SCANLON KJ
      OLIGONUCLEOTIDES AS MODULATORS OF CANCER GENE-EXPRESSION

      Pharmacology & therapeutics
    18. BOUFFARD DY; OHKAWA T; KIJIMA H; IRIE A; SUZUKI T; CURCIO LD; HOLM PS; SASSANI A; SCANLON KJ
      OLIGONUCLEOTIDE MODULATION OF MULTIDRUG-RESISTANCE

      European journal of cancer
    19. SOBOL RE; SCANLON KJ
      CANCER GENE-THERAPY - CLINICAL PERSPECTIVE 1995

      Cancer gene therapy
    20. SCANLON KJ; KIJIMA H; ISHIDA H
      REVERSAL OF DRUG-RESISTANCE IN HUMAN CARCINOMAS BY ANTIONCOGENE RIBOZYMES

      Cytotechnology
    21. ZHANG YA; NEUMUNAITIS J; MUES G; SCANLON KJ; TONG AW
      IN-VITRO SUPPRESSION OF HUMAN NON-SMALL-CELL LUNG-CANCER (NSCLC) CELL-GROWTH BY AN ANTI-K-RAS RIBOZYME

      The FASEB journal
    22. JIAO L; XIA L; HORNG M; KASHFIAN BI; KASHANISABET M; SCANLON KJ
      ONCOGENE EXPRESSION IN MULTIDRUG-RESISTANT OVARIAN CARCINOMAS

      Onkologie
    23. OHTA Y; KIJIMA H; OHKAWA T; KASHANISABET M; SCANLON KJ
      TISSUE-SPECIFIC EXPRESSION OF AN ANTI-RAS RIBOZYME INHIBITS PROLIFERATION OF HUMAN-MALIGNANT MELANOMA-CELLS

      Nucleic acids research
    24. OHTA Y; KASHANISABET M; SCANLON KJ
      SUPPRESSION OF ME MALIGNANT PHENOTYPE OF MELANOMA-CELLS BY ANTIONCOGENE RIBOZYMES

      Journal of investigative dermatology
    25. OHTA Y; KIJIMA H; KASHANISABET M; SCANLON KJ
      SUPPRESSION OF THE MALIGNANT PHENOTYPE OF MELANOMA-CELLS BY ANTIONCOGENE RIBOZYMES

      Journal of investigative dermatology
    26. MAELANDSMO GM; HOVIG E; SKREDE M; ENGEBRAATEN O; FLORENES VA; MYKLEBOST O; GRIGORIAN M; LUKANIDIN E; SCANLON KJ; FODSTAD O
      REVERSAL OF THE IN-VIVO METASTATIC PHENOTYPE OF HUMAN TUMOR-CELLS BY AN ANTI-CAPL (MTS1) RIBOZYME

      Cancer research
    27. KASHANISABET M; SCANLON KJ
      APPLICATION OF RIBOZYMES TO CANCER GENE-THERAPY

      Cancer gene therapy
    28. SOBOL RE; SCANLON KJ
      CANCER GENE-THERAPY CLINICAL-TRIALS

      Cancer gene therapy
    29. SCANLON KJ; OHTA Y; ISHIDA H; KIJIMA H; OHKAWA T; KAMINSKI A; TSAI J; HORNG G; KASHANISABET M
      OLIGONUCLEOTIDE-MEDIATED MODULATION OF MAMMALIAN GENE-EXPRESSION

      The FASEB journal
    30. KIJIMA H; ISHIDA H; OHKAWA T; KASHANISABET M; SCANLON KJ
      THERAPEUTIC APPLICATIONS OF RIBOZYMES

      Pharmacology & therapeutics
    31. FENG M; CABRERA G; DESHANE J; SCANLON KJ; CURIEL DT
      NEOPLASTIC REVERSION ACCOMPLISHED BY HIGH-EFFICIENCY ADENOVIRAL-MEDIATED DELIVERY OF AN ANTI-RAS RIBOZYME

      Cancer research
    32. HILL BT; SCANLON KJ; HANSSON J; HARSTRICK A; PERA M; FICHTINGERSCHEPMAN AMJ; SHELLARD SA
      DEFICIENT REPAIR OF CISPLATIN-DNA ADDUCTS IDENTIFIED IN HUMAN TESTICULAR TERATOMA CELL-LINES ESTABLISHED FROM TUMORS FROM UNTREATED PATIENTS

      European journal of cancer
    33. SOBOL RE; SCANLON KJ
      UNTITLED - EDITORIAL

      Cancer gene therapy
    34. TAVERNA P; HANSSON J; SCANLON KJ; HILL BT
      GENE-EXPRESSION IN X-IRRADIATED HUMAN TUMOR-CELL LINES EXPRESSING CISPLATIN RESISTANCE AND ALTERED DNA-REPAIR CAPACITY

      Carcinogenesis
    35. SCANLON KJ; ISHIDA H; KASHANISABET M
      RIBOZYME-MEDIATED REVERSAL OF THE MULTIDRUG-RESISTANT PHENOTYPE

      Proceedings of the National Academy of Sciences of the United Statesof America
    36. KASHANISABET M; FUNATO T; FLORENES VA; FODSTAD O; SCANLON KJ
      SUPPRESSION OF THE NEOPLASTIC PHENOTYPE IN-VIVO BY AN ANTI-RAS RIBOZYME

      Cancer research
    37. HOLM PS; SCANLON KJ; DIETEL M
      REVERSION OF MULTIDRUG-RESISTANCE IN THE P-GLYCOPROTEIN-POSITIVE HUMAN PANCREATIC-CELL LINE (EPP85-181RDB) BY INTRODUCTION OF A HAMMERHEAD RIBOZYME

      British Journal of Cancer
    38. FUNATO T; SHITARA T; TONE T; JIAO L; KASHANISABET M; SCANLON KJ
      SUPPRESSION OF H-RAS-MEDIATED TRANSFORMATION IN NIH3T3 CELLS BY A RASRIBOZYME

      Biochemical pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/06/20 alle ore 02:28:58